fbpx

Category: Blog

Black Friday weekend is just a day away but you can already take advantage of the so much-anticipated shopping event right now.

Read More

We are proud to announce that ChemDiv has developed CHEMVIDIA, an Analytical System with AI elements, based on pubmed data base, which is designed to predict novel trends in small-molecule drug discovery.

Read More

ChemDiv presents a brand new library – Opportunistic Pathogens of Immunocompromised Hosts Annotated Library (OPICH library), which consists of over 2,500 compounds.

Read More

ChemDiv offers you CADD support as a complementary service for your discovery projects.

Read More

ChemDiv presents the new 3D-Pharmacophore Based Diversity Library, Set of small-molecule compounds with high diversity in terms of potential pharmacophore points.

Read More

Preplated compounds libraries from ChemDiv,Inc (10-100ul@10mM per well DMSO solutions frozen. Designed for customers from ACADEMIA)

Read More

Search and select chemistry sets by:

26 therapeutic areasTarget namesMechanism of actionStructural motifs

Stay informed of new library arrivals.Sort through over 100 libraries in 1 click and quickly select the best library …

Read More

ChemDiv opens you gate to global market.

By partnering with ChemDiv, you gain access to pharma, biotech and academia customers worldwide.

Submit us your catalog of screening compounds and building blocks. …

Read More

Online stock of the world largest screening compounds & building blocks collection.New arrivals every month. >500,000 for the last 5 years. Designed and synthesized at ChemDiv.Search by substructure, exact and similarity. Add to shopping …

Read More

Download now ChemDiv’s collection of 1.6 stock available screening compounds

Read More

X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X